Effects of Hyperthermic Baths on Motor Symptoms of Parkinson's Disease Trial N/A Completed Dec. 28, 2020
Establishment of Clinical Basis for Hematopoietic Growth Factors Therapy in Brain Injury Trial Phase 1 Unknown Dec. 27, 2020
Safety and Efficacy of AQW051 in L-dopa Induced Dyskinesias in Patients With Parkinson's Disease Trial Phase 2 Completed Dec. 23, 2020
Asymmetric DBS for PD : A Multicenter, Prospective, Single Arm, Open Label Study Trial N/A Not yet recruiting Dec. 23, 2020
Spinal Cord Stimulation Therapy for Freezing of Gait in Parkinson's Syndrome Patients Trial N/A Unknown Dec. 23, 2020
Evaluation of the Efficacy and Safety of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias Trial Phase 2 Completed Dec. 22, 2020
Open-label, Long-term Safety Extension Study of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias Trial Phase 2 Completed Dec. 22, 2020
Efficacy and Safety of AFQ056 When Combined With Increased Doses of L-dopa in Parkinson's Disease Patients With Moderate-severe L-dopa Induced Dyskinesia Trial Phase 2 Completed Dec. 22, 2020
Open Label, Safety, Tolerability and Efficacy of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias Trial Phase 2 Completed Dec. 22, 2020
Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias Trial Phase 2 Completed Dec. 22, 2020
Evaluation of [18F]PI-2620 as a Potential Positron Emission Computed Tomography Radioligand for Imaging Tau Protein in the Brain Trial Early Phase 1 Completed Dec. 13, 2020
Binding of Foliglurax to Regions in the Brain in Healthy Participants and in Patients With Parkinson's Disease (PD) Trial Phase 1 Terminated Dec. 8, 2020
Health Related Quality of Life in LCIG Patients and LCIG Eligible Patients Continuing Oral Therapy Trial N/A Completed Dec. 8, 2020
Effect of Dual Task on Upper and Lower Extremity Skills in Parkinson's Disease Trial N/A Completed Dec. 2, 2020